ScripIndustry’s efforts to get ahead of COVID-19 have been continuing apace, with a growing focus on how to improve on vaccines, ensure lasting protection and retain effectiveness in the face of emerging v
Medtech InsightIn a move that has defied recommendations from health bodies, charities and doctors, the board of directors of t Vectura Group have recommended shareholders accept Philip Morris International (PMI)
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Seagen, RemeGen Partner Outside Asia, E
Pink SheetThe US Food and Drug Administration will hear from several new voices during what is scheduled to be an unconventional Vaccines and Related Biological Products Advisory Committee on the Pfizer Inc. /